← Leaderboards
Silva Markovic-Plese
University Of North Carolina Chapel Hill
$3,374,572
Attributed
$3,374,572
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $625K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,374,572 · 4
By mechanism
R01$1,963,550 · 1
K08$828,090 · 1
R21$430,932 · 1
R03$152,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Timothy Charles Nichols$20,287,823
- Jennifer Susan Smith$7,704,992
- Richard C Boucher$55,332,929
- Sara J. Ward$5,152,771
- Richard Vance Wolfenden$4,024,278
Others in their field
Top investigators on “Cd4 Positive T Lymphocytes”
- Barton F Haynes · Duke University$185,201,094
- James Dennis Neaton · Northwestern University$75,155,718
- Sharon A Nachman · Johns Hopkins University$74,725,055
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$62,274,832
- Dennis R. Burton · Scripps Research Institute$60,411,078
- Rama Rao Amara · Emory University$55,598,235
Research focus
Cd4 Positive T LymphocytesMultiple SclerosisCellsCytokineBaseInflammatory InfiltrateRelapsing-Remitting Multiple SclerosisMediatingCell Differentiation ProcessExperimental Autoimmune EncephalomyelitisIn VitroAntigensResponseInflammatoryMolecularPeripheralAutoimmune ResponsesInterleukin-11Cerebrospinal FluidDemyelinating DiseasesMonoclonal AntibodiesAnimalsExperimental StudyImmunomodulatory Therapies
Grant awards (14)
The Role of IL-II in the development of autoimmune response in multiple sclerosis$390,000
R01 · FY2022 · AI · contact PI
Immunoregulatory effect of microparticle delivered STING agonist in the control of experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS)$195,966
R21 · FY2022 · AI · contact PI
The Role of IL-II in the development of autoimmune response in multiple sclerosis$390,000
R01 · FY2021 · AI · contact PI
Immunoregulatory effect of microparticle delivered STING agonist in the control of experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS)$234,966
R21 · FY2021 · AI · contact PI
The Role of IL-II in the development of autoimmune response in multiple sclerosis$389,850
R01 · FY2020 · AI · contact PI
The Role of IL-II in the development of autoimmune response in multiple sclerosis$389,850
R01 · FY2019 · AI · contact PI
The Role of IL-II in the development of autoimmune response in multiple sclerosis$403,850
R01 · FY2018 · AI · contact PI
The Role of IL-11 in Development of Th17-mediated Autoimmune Response in EAE$76,000
R03 · FY2015 · AI · contact PI
The Role of IL-11 in Development of Th17-mediated Autoimmune Response in EAE$76,000
R03 · FY2014 · AI · contact PI
THE MECHANISMS OF AUTOIMMUNE RESPONSE INITIATION IN MULTIPLE SCLEROSIS$165,618
K08 · FY2007 · NS · contact PI
THE MECHANISMS OF AUTOIMMUNE RESPONSE INITIATION IN MS$165,618
K08 · FY2006 · NS · contact PI
THE MECHANISMS OF AUTOIMMUNE RESPONSE INITIATION IN MS$165,618
K08 · FY2005 · NS
THE MECHANISMS OF AUTOIMMUNE RESPONSE INITIATION IN MS$165,618
K08 · FY2004 · NS
THE MECHANISMS OF AUTOIMMUNE RESPONSE INITIATION IN MS$165,618
K08 · FY2003 · NS